FDA Revitalization Bill Progresses In Senate
A Senate Committee approved a bill Wednesday that would require the U.S. Food and Drug Administration to monitor safety of new drugs and renew a law allowing the agency to collect...To view the full article, register now.
Already a subscriber? Click here to view full article